PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1620.28%
Net income growth above 1.5x CX's 188.72%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
27.95%
D&A growth well above CX's 8.63%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
23.14%
SBC growth of 23.14% while CX is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
200.00%
Well above CX's 60.35% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-363.96%
AR is negative yoy while CX is 64.20%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
116.72%
Inventory growth well above CX's 141.34%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Growth well above CX's 77.39%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-190.32%
Both negative yoy, with CX at -116.73%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
318.04%
Operating cash flow growth at 75-90% of CX's 389.27%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-18.06%
Negative yoy CapEx while CX is 2.14%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
80.16%
Some acquisitions while CX is negative at -97.13%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-137.77%
We reduce yoy other investing while CX is 192.40%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-1.45%
Both yoy lines negative, with CX at -144.94%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-200.00%
We cut debt repayment yoy while CX is 264.08%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Buyback growth of 200.00% while CX is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.